Tonix Pharmaceuticals (NASDAQ:TNXP) Raised to Sell at StockNews.com

StockNews.com upgraded shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Rating) to a sell rating in a report issued on Saturday morning. Tonix Pharmaceuticals Price Performance Shares of NASDAQ:TNXP opened at $1.63 on Friday. The business’s fifty day moving average price is $3.06 and its two-hundred day moving average price is $3.91. Tonix Pharmaceuticals has a […]

Related Keywords

,York Mellon Corp ,Institutional Trading Of Tonix Pharmaceuticals ,Nasdaq ,Charles Schwab Investment Management Inc ,Jpmorgan Chase Co ,News Ratings For Tonix Pharmaceuticals Daily ,Tonix Pharmaceuticals Price Performance ,Northern Trust Corp ,Tonix Pharmaceuticals ,Tonix Pharmaceuticals Holding Corp ,Blackrock Inc ,Get Rating ,New York Mellon Corp ,Schwab Investment Management ,Trust Corp ,Pharmaceuticals Holding ,Tonix Pharmaceuticals Daily ,Nasdaq Tnxp ,Tnxp ,Medical ,Upgrade ,Stocknews Com ,